CUBIST PHARMACEUTICALS INC - FORM 10-K - EX-23.2 - EXHIBIT 23.2 - February 26, 2010

Attached files

file filename
10-K - 10-K - CUBIST PHARMACEUTICALS INCa2196647z10-k.htm
EX-2.2 - EXHIBIT 2.2 - CUBIST PHARMACEUTICALS INCa2196647zex-2_2.htm
EX-10.31 - EXHIBIT 10.31 - CUBIST PHARMACEUTICALS INCa2196647zex-10_31.htm
EX-32.2 - EXHIBIT 32.2 - CUBIST PHARMACEUTICALS INCa2196647zex-32_2.htm
EX-21.1 - EXHIBIT 21.1 - CUBIST PHARMACEUTICALS INCa2196647zex-21_1.htm
EX-31.2 - EXHIBIT 31.2 - CUBIST PHARMACEUTICALS INCa2196647zex-31_2.htm
EX-23.1 - EXHIBIT 23.1 - CUBIST PHARMACEUTICALS INCa2196647zex-23_1.htm
EX-32.1 - EXHIBIT 32.1 - CUBIST PHARMACEUTICALS INCa2196647zex-32_1.htm
EX-31.1 - EXHIBIT 31.1 - CUBIST PHARMACEUTICALS INCa2196647zex-31_1.htm
EX-10.60 - EXHIBIT 10.60 - CUBIST PHARMACEUTICALS INCa2196647zex-10_60.htm
EX-10.57 - EXHIBIT 10.57 - CUBIST PHARMACEUTICALS INCa2196647zex-10_57.htm
EX-10.58 - EXHIBIT 10.58 - CUBIST PHARMACEUTICALS INCa2196647zex-10_58.htm
EX-10.61 - EXHIBIT 10.61 - CUBIST PHARMACEUTICALS INCa2196647zex-10_61.htm
EX-10.52 - EXHIBIT 10.52 - CUBIST PHARMACEUTICALS INCa2196647zex-10_52.htm
EX-10.56 - EXHIBIT 10.56 - CUBIST PHARMACEUTICALS INCa2196647zex-10_56.htm
EX-10.47 - EXHIBIT 10.47 - CUBIST PHARMACEUTICALS INCa2196647zex-10_47.htm
EX-10.54 - EXHIBIT 10.54 - CUBIST PHARMACEUTICALS INCa2196647zex-10_54.htm
EX-10.51 - EXHIBIT 10.51 - CUBIST PHARMACEUTICALS INCa2196647zex-10_51.htm
EX-10.59 - EXHIBIT 10.59 - CUBIST PHARMACEUTICALS INCa2196647zex-10_59.htm
EX-10.33 - EXHIBIT 10.33 - CUBIST PHARMACEUTICALS INCa2196647zex-10_33.htm
EX-10.55 - EXHIBIT 10.55 - CUBIST PHARMACEUTICALS INCa2196647zex-10_55.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.2

CONSENT OF INDEPENDENT VALUATION FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333,162764, 333-162763, 333-155352, 333-148455, 333-148454, 333-136937, 333-118065, 333-106388, 333-101908, 333-99739, 333-65385, 333-65383, 333-60168, 333-60152, 333-54140, 333-49522, 333-32178, 333-25707, 333-124210, 333-126225 and 333-132248) of Cubist Pharmaceuticals, Inc. of our report dated as of December 31, 2009, relating to the valuation of financial securities which appears in this Form 10-K.

/s/ HOULIHAN SMITH & COMPANY INC.
 Houlihan Smith & Company Inc.
Chicago, Illinois
February 26, 2010
 		   



QuickLinks

Stock widget

Investing forum

CUBIST PHARMACEUTICALS INC Reports

Also read